Fluorescence imaging analysis of distribution of indocyanine green in molecular and nanoform in tumor model

D Farrakhova, Y Maklygina, I Romanishkin… - Photodiagnosis and …, 2022 - Elsevier
Background The efficient intraoperative identification of tumors requires the development of
highly specific near-infrared (NIR) probes as contrast agents. One of the most effective dyes …

Characterization of normal breast tissue heterogeneity using time-resolved near-infrared spectroscopy

T Svensson, J Swartling, P Taroni… - Physics in Medicine …, 2005 - iopscience.iop.org
In recent years, extensive efforts have been made in developing near-infrared optical
techniques to be used in detection and diagnosis of breast cancer. Variations in optical …

Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening

S Bhatnagar, KD Verma, Y Hu, E Khera… - Molecular …, 2018 - ACS Publications
Molecular imaging is advantageous for screening diseases such as breast cancer by
providing precise spatial information on disease-associated biomarkers, something neither …

Near-Infrared Characterization of Breast Tumors In Vivo using Spectrally-Constrained Reconstruction

S Srinivasan, BW Pogue, B Brooksby… - … in cancer research …, 2005 - journals.sagepub.com
Multi-wavelength Near-Infrared (NIR) Tomography was utilized in this study to non-
invasively quantify physiological parameters of breast tumors using direct spectral …

NIR spectroscopic detection of breast cancer

S Nioka, B Chance - Technology in cancer research & …, 2005 - journals.sagepub.com
Near infrared spectroscopy (NIRS) utilizes intrinsic optical absorption signals of blood,
water, and lipid concentration available in the NIR window (600–1000 nm) as well as a …

[HTML][HTML] Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)

A Wall, T Persigehl, P Hauff, K Licha, M Schirner… - Breast Cancer …, 2008 - Springer
Introduction Use of fluorescence imaging in oncology is evolving rapidly, and nontargeted
fluorochromes are currently being investigated for clinical application. Here, we investigated …

Optical imaging in breast cancer diagnosis: the next evolution

M Herranz, A Ruibal - Journal of oncology, 2012 - Wiley Online Library
Breast cancer is one of the most common cancers among the population of the Western
world. Diagnostic methods include mammography, ultrasound, and magnetic resonance; …

Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in …

S Zanganeh, Y Xu, CV Hamby… - … of biomedical optics, 2013 - spiedigitallibrary.org
To develop an indocyanine green (ICG) tracer with slower clearance kinetics, we explored
ICG-encapsulating liposomes (Lip) in three different formulations: untargeted (Lip/ICG) …

Assessing indocyanine green pharmacokinetics in mouse liver with a dynamic diffuse fluorescence tomography system

Y Zhang, L Zhang, G Yin, W Ma… - Journal of Biophotonics, 2018 - Wiley Online Library
Fluorescence pharmacokinetic rates in tissues can provide additional specific and
quantitative physiological and pathological information for evaluating organ function. This …

[HTML][HTML] A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions

RX Xu, DC Young, JJ Mao, SP Povoski - Breast cancer research, 2007 - Springer
Introduction Characterizing and differentiating between malignant tumors, benign tumors,
and normal breast tissue is increasingly important in the patient presenting with breast …